Psychopharmacologic management of opioid-dependent women during pregnancy

Peter R. Martin; Amelia M. Arria; Gabriele Fischer; Karol Kaltenbach; Sarah H. Heil; Susan M. Stine; Mara G. Coyle; Peter Selby; Hendree E. Jones

doi:10.1080/10550490902772975

Psychopharmacologic management of opioid-dependent women during pregnancy

Peter R. Martin, Amelia M. Arria, Gabriele Fischer, Karol Kaltenbach, Sarah H. Heil, Susan M. Stine, Mara G. Coyle, Peter Selby, Hendree E. Jones

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Illicit drug use during pregnancy presents complex clinical challenges, including reducing drug use and treating psychiatric disorders. Pharmacologic treatment of psychiatric disorders in a pregnant woman requires an evaluation of the balance between potential clinical benefit and the risk of potential neonatal consequences. This study describes psychiatric symptoms in 111 opioid-dependent pregnant women and their prescribed psychotropic medications. Hypomania, generalized anxiety disorder and depression were the most common disorders for which psychiatric symptoms were endorsed. Over half of women studied were prescribed some form of psychoactive medication during pregnancy. Pharmacologic vs. non-pharmacologic treatment approaches in this patient population are discussed.

Original language	English (US)
Pages (from-to)	148-156
Number of pages	9
Journal	American Journal on Addictions
Volume	18
Issue number	2
DOIs	https://doi.org/10.1080/10550490902772975
State	Published - Mar 2009
Externally published	Yes

ASJC Scopus subject areas

Medicine (miscellaneous)
Clinical Psychology
Psychiatry and Mental health

Access to Document

10.1080/10550490902772975

Cite this

@article{b102f0f65f624be087ac462a48475446,

title = "Psychopharmacologic management of opioid-dependent women during pregnancy",

abstract = "Illicit drug use during pregnancy presents complex clinical challenges, including reducing drug use and treating psychiatric disorders. Pharmacologic treatment of psychiatric disorders in a pregnant woman requires an evaluation of the balance between potential clinical benefit and the risk of potential neonatal consequences. This study describes psychiatric symptoms in 111 opioid-dependent pregnant women and their prescribed psychotropic medications. Hypomania, generalized anxiety disorder and depression were the most common disorders for which psychiatric symptoms were endorsed. Over half of women studied were prescribed some form of psychoactive medication during pregnancy. Pharmacologic vs. non-pharmacologic treatment approaches in this patient population are discussed.",

author = "Martin, {Peter R.} and Arria, {Amelia M.} and Gabriele Fischer and Karol Kaltenbach and Heil, {Sarah H.} and Stine, {Susan M.} and Coyle, {Mara G.} and Peter Selby and Jones, {Hendree E.}",

year = "2009",

month = mar,

doi = "10.1080/10550490902772975",

language = "English (US)",

volume = "18",

pages = "148--156",

journal = "American Journal on Addictions",

issn = "1055-0496",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Psychopharmacologic management of opioid-dependent women during pregnancy

AU - Martin, Peter R.

AU - Arria, Amelia M.

AU - Fischer, Gabriele

AU - Kaltenbach, Karol

AU - Heil, Sarah H.

AU - Stine, Susan M.

AU - Coyle, Mara G.

AU - Selby, Peter

AU - Jones, Hendree E.

PY - 2009/3

Y1 - 2009/3

N2 - Illicit drug use during pregnancy presents complex clinical challenges, including reducing drug use and treating psychiatric disorders. Pharmacologic treatment of psychiatric disorders in a pregnant woman requires an evaluation of the balance between potential clinical benefit and the risk of potential neonatal consequences. This study describes psychiatric symptoms in 111 opioid-dependent pregnant women and their prescribed psychotropic medications. Hypomania, generalized anxiety disorder and depression were the most common disorders for which psychiatric symptoms were endorsed. Over half of women studied were prescribed some form of psychoactive medication during pregnancy. Pharmacologic vs. non-pharmacologic treatment approaches in this patient population are discussed.

AB - Illicit drug use during pregnancy presents complex clinical challenges, including reducing drug use and treating psychiatric disorders. Pharmacologic treatment of psychiatric disorders in a pregnant woman requires an evaluation of the balance between potential clinical benefit and the risk of potential neonatal consequences. This study describes psychiatric symptoms in 111 opioid-dependent pregnant women and their prescribed psychotropic medications. Hypomania, generalized anxiety disorder and depression were the most common disorders for which psychiatric symptoms were endorsed. Over half of women studied were prescribed some form of psychoactive medication during pregnancy. Pharmacologic vs. non-pharmacologic treatment approaches in this patient population are discussed.

UR - http://www.scopus.com/inward/record.url?scp=66549120324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66549120324&partnerID=8YFLogxK

U2 - 10.1080/10550490902772975

DO - 10.1080/10550490902772975

M3 - Article

C2 - 19283567

AN - SCOPUS:66549120324

SN - 1055-0496

VL - 18

SP - 148

EP - 156

JO - American Journal on Addictions

JF - American Journal on Addictions

IS - 2

ER -

Psychopharmacologic management of opioid-dependent women during pregnancy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this